Bibliography Ralf Bender's Selected Bibliography

Go to:   - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002 - 2001 - 2000 and before -

Line


  1. BROCKHAUS, A.C., GROUVEN, U. & BENDER, R. (2016):
    Performance of the Peto odds ratio compared to the usual odds ratio estimator in the case of rare events.
    Biom. J. 58, 1428–1444.

  2. SCHMOOR, C., BENDER, R., BEYERSMANN, J., KIESER, M. & SCHUMACHER, M. (2016):
    Adverse event development in clinical oncology trials.
    Lancet Oncol. 17, e263-e264.   Open Access

  3. BENDER, R., BECKMANN, L. & LANGE, S. (2016):
    Biometrical issues in the analysis of adverse events within the benefit assessment of drugs.
    Pharm. Stat. 15, 292-296.   Open Access

  4. VERONIKI, A.A., JACKSON, D., VIECHTBAUER, W., BENDER, R., BOWDEN, J., KNAPP, G., KUSS, O. HIGGINS, J.P.T., LANGAN, D. & SALANTI, G. (2016):
    Methods to estimate the between-study variance and its uncertainty in meta-analysis..
    Res. Syn. Methods 7, 55-79.   Open Access

  5. SKIPKA, G., WIESELER, B., KAISER, T., THOMAS, S., BENDER, R., WINDELER, J. & LANGE, S. (2016):
    A methodological approach to determine minor, considerable and major treatment effects in the early benefit assessment of new drugs.
    Biom. J. 58, 43-58.   Open Access

  6. KIEFER, C., STURTZ, S. & BENDER, R. (2015):
    Indirekte Vergleiche und Netzwerk-Metaanalysen: Schätzung von Effekten bei fehlenden direkten Vergleichsstudien − Teil 22 der Serie zur Bewertung wissenschaftlicher Publikationen.
    German version:
    Dtsch. Ärztebl. 112, 803-808.   Open Access
    Indirect comparisons and network meta-analyses: Estimation of effects in the absence of head-to-head trials − Part 22 of a series on evaluation of scientific publications.
    English version: Dtsch. Ärztebl. Int. 112, 803-808.   Open Access

  7. VERONIKI, A.A., JACKSON, D., VIECHTBAUER, W., BENDER, R., KNAPP, G., KUSS, O. & LANGAN, D. (2015):
    Recommendations for quantifying the uncertainty in the summary intervention effect and estimating the between-study heterogeneity variance in random-effects meta-analysis.
    Cochrane Database Syst. Rev. 2015 (Suppl. 1), 25-27.   Open Access

  8. GROUVEN, U., SIERING, U., BENDER, R., VERVÖLGYI, V. & LANGE, S. (2015):
    Seltene Erkrankungen: Randomisierte kontrollierte Studien auch hier der Goldstandard.
    Dtsch. Ärztebl. 112, A3268-A328.   Open Access

  9. BROCKHAUS, A.C., BENDER, R. & SKIPKA, G. (2014):
    The Peto odds ratio viewed as a new effect measure.
    Stat. Med. 33, 4861-4874.

  10. ZÖLLER, D. & BENDER, R. (2014):
    Berechnung von Konfidenzintervallen für das relative Risiko mit SAS.
    In: FRIEDE, T., HILGERS, R. & MINKENBERG, R. (Eds.): KSFE 2014 − Proceedings der 18. Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE), Universität Göttingen, 27.03.-28.03.2014, pp. 381-398.
    Shaker, Aachen.   Open Access

  11. LAUBENDER, R.P. & BENDER, R. (2014):
    A note on calculating asymptotic confidence intervals for the adjusted risk difference (RD) and number needed to treat (NNT) in the Cox regression model.
    Stat. Med. 33, 798–810.    Correction:   Stat. Med. 33, 810–811   Open Access

  12. NEWCOMBE, R.G. & BENDER, R. (2014):
    Implementing GRADE − calculating the risk difference from the baseline risk and the relative risk.
    Evid. Based Med. 19, 6-8.   Open Access

  13. BENDER, R., KROMP, M., KIEFER, C. & STURTZ, S. (2014):
    Estimation of numbers needed to treat should be based on absolute risks.
    J. Clin. Epidemiol. 67, 238-239.   Open Access

  14. WELZ, A. & BENDER, R. (2013):
    Punkt- und Intervallschätzung adjustierter NNT-Maße im Cox-Modell mit Hilfe von SAS.
    In: MUCHE, R. & MINKENBERG, R. (Eds.): KSFE 2013 − Proceedings der
    17. Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE), Universität Ulm, 28.02.-01.03.2013, pp. 417-426.
    Shaker, Aachen.   Open Access

  15. BENDER, R., KROMP, M., KIEFER, C. & STURTZ, S. (2013):
    Absolute risks rather than incidence rates should be used to estimate the number needed to treat from time-to-event data.
    J. Clin. Epidemiol. 66, 1038-1044.

  16. STURTZ, S. & BENDER, R.(2012):
    Unsolved issues of mixed treatment comparison meta-analysis: Network size and inconsistency.
    Res. Syn. Meth. 3, 300-311.

  17. GUDDAT, C., GROUVEN, U., BENDER, R. & SKIPKA, G. (2012):
    A note on the graphical presentation of prediction intervals in random-effects meta-analyses.
    Sys. Rev. 1, 34.   Open Access

  18. BENDER, R.(2012):
    Incorrect calculation of numbers needed to treat affects confidence intervals more often than point estimates.
    J. Clin. Epidemiol. 65, 808.   Open Access

  19. BENDER, R.(2012):
    Adequate methods should be used to compare the features of effect measures.
    J. Clin. Epidemiol. 65, 462.   Open Access

  20. BENDA, N. & BENDER, R.(2011):
    Multiplicity issues in clinical trials.
    Biom. J. 53, 873-874.

  21. BENDER, R. & VERVÖLGYI, V. (2011):
    Die Berechnung adjustierter NNTs in randomisierten kontrollierten Studien.
    In: ORTSEIFEN, C., RAMROTH, H., WEIRES, M. & MINKENBERG, R. (Eds.): KSFE 2011 − "Voneinander lernen”, Proceedings der 15. Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE), Ruprechts-Karls-Universität Heidelberg, 24.-25.02.2011, pp. 51-58.
    Shaker, Aachen.   Open Access

  22. VERVÖLGYI, E., KROMP, M., SKIPKA, G., BENDER, R. & KAISER, T.(2011):
    Reporting of loss to follow-up information in randomised controlled trials with time-to-event outcomes: A literature survey.
    BMC Med. Res. Methodol. 11, 130.   Open Access

  23. BENDER, R., KOCH, A., SKIPKA, G., KAISER, T. & LANGE, S. (2011):
    The assessment of heterogeneity is mandatory in clinical trials and systematic reviews.
    J. Clin. Epidemiol. 64, 452.

  24. BENDER, R., KOCH, A., SKIPKA, G., KAISER, T. & LANGE, S (2010):
    No inconsistent trial assessments by NICE and IQWiG: Different assessment goals may lead to different assessment results regarding subgroup analyses.
    J. Clin. Epidemiol. 63, 1305-1307.

  25. SKIPKA, G. & BENDER, R. (2010):
    Assessment of intervention effects in the case of heterogeneity between three subgroups within the framework of systematic reviews.
    Meth. Inf. Med. 49, 613-617.   Open Access

  26. GEHRMANN, U., KUSS, O., WELLMANN, J. & BENDER, R. (2010):
    Logistic regression was preferred to estimate risk differences and numbers needed to be exposed adjusted for covariates.
    J. Clin. Epidemiol. 63, 1223-1231.

  27. BENDER, R. (2010):
    Using and interpreting adjusted NNT measures in biomedical research.
    Open Dent. J. 4, 72-76.   Open Access

  28. BENDER, R. & VERVÖLGYI, V. (2010):
    Estimating adjusted NNTs in randomised controlled trials with binary outcomes: A simulation study.
    Contemp. Clin. Trials 31, 498-505.

  29. STANG, A., POOLE, C. & BENDER, R. (2010):
    Common problems related to the use of number needed to treat.
    J. Clin. Epidemiol. 63, 820-825.

  30. HORVATH, K., KOCH, K., JEITLER, K., MATYAS, E., BENDER, R., BASTIAN, H., LANGE, S. & SIEBENHOFER, A. (2010):
    Effects of treatment in women with gestational diabetes mellitus: Systematic review and meta-analysis.
    BMJ 340, c1395.   Open Access

  31. LAUBENDER, R.P. & BENDER, R. (2010):
    Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model.
    Stat. Med. 29, 851-859.

  32. BENDER, R. & KUSS, O. (2010):
    Methods to calculate relative risks, risk differences, and numbers needed to treat from logistic regression.
    J. Clin. Epidemiol. 63, 7-8.

  33. GROUVEN, U., HEMKENS, L.G., BENDER, R. & SAWICKI, P.T. (2010):
    Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter].
    Diabetologia 53, 209-211.

  34. HEMKENS, L.G., BENDER, R., GROUVEN, U. & SAWICKI, P.T. (2009):
    Insulin glargine and cancer.
    Lancet 374, 1743-1744.   Open Access

  35. HEMKENS, L.G., GROUVEN, U., BENDER, R., GÜNSTER, C., GUTSCHMIDT, S., SELKE, G.W. & SAWICKI, P.T. (2009):
    Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: A cohort study.
    Diabetologia 52, 1732-1744.   Open Access

  36. HILDEBRANDT, M., VERVÖLGYI, E. & BENDER, R. (2009):
    Calculation of NNTs in RCTs with time-to-event outcomes: A literature review.
    BMC Med. Res. Methodol. 9, 21.   Open Access

  37. LÜHRMANN, P.M., BENDER, R., EDELMANN-SCHÄFER, B. & NEUHÄUSER-BERTHOLD, M. (2009):
    Longitudinal changes in energy expenditure in an elderly German population: A 12 year follow-up.
    Eur. J. Clin. Nutr. 63, 986-992.

  38. BENDER, R. (2009):
    Introduction to the use of regression models in epidemiology.
    In: VERMA, M. (Ed.): Cancer Epidemiology, Vol. 1: Host Susceptibility Factors, pp. 179-195.  Humana Press, Totowa, NJ.

  39. GROUVEN, U., KÜCHENHOFF, H., SCHRÄDER, P. & BENDER, R. (2008):
    Flexible regression models are useful tools to calculate and assess threshold values in the context of minimum provider volumes.
    J. Clin. Epidemiol. 61, 1125-1131.

  40. BENDER, R. & GROUVEN, U. (2008):
    Berechnung von Konfidenzintervallen für die Population Impact Number (PIN).
    In: HILGERS, R.-D., HEUSSEN, N., HERFF, W. & ORTSEIFEN, C. (Eds.): KSFE 2008 − Proceedings der 12. Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE), pp. 41-47.
    Shaker, Aachen.   Open Access

  41. BENDER, R., BUNCE, C., CLARKE, M., GATES, S., LANGE, S., PACE, N.L. & THORLUND, K. (2008):
    Attention should be given to multiplicity issues in systematic reviews.
    J. Clin. Epidemiol. 61, 857-865.

  42. BENDER, R. (2007):
    Simulation von Überlebenszeiten mit Hilfe von SAS®.
    In: MUCHE, R. & BÖDEKER, R.-H. (Eds.): KSFE 2007 − Proceedings der
    11. Konferenz der SAS-Anwender in Forschung und Entwicklung (KSFE), pp. 55-62.
    Shaker, Aachen.   Open Access

  43. BENDER, R., KUSS, O., HILDEBRANDT, M. & GEHRMANN, U. (2007):
    Estimating adjusted NNT measures in logistic regression analysis.
    Stat. Med. 26, 5586-5595.

  44. SCHRÄDER, P., GROUVEN, U. & BENDER, R. (2007):
    Können Mindestmengen für Knieprothesen anhand von Routinedaten errechnet werden? Ergebnisse einer Schwellenwertanalyse mit Daten der externen stationären Qualitätssicherung.
    Orthopäde 36, 570-576.

  45. LANGE, S. & BENDER, R. (2007):   Median oder Mittelwert?   Dtsch. Med. Wschr. 132, e1-e2.   Open Access
  46. LANGE, S. & BENDER, R. (2007):   Quantile, empirische Verteilungsfunktion und Box Plot.   Dtsch. Med. Wschr. 132, e3-e4.   Open Access
  47. LANGE, S. & BENDER, R. (2007):   Variabilitätsmaße.   Dtsch. Med. Wschr. 132, e5-e6.   Open Access
  48. LANGE, S. & BENDER, R. (2007):   Das Histogramm.   Dtsch. Med. Wschr. 132, e7-e8.   Open Access
  49. LANGE, S. & BENDER, R. (2007):   Lineare Regression und Korrelation.   Dtsch. Med. Wschr. 132, e9-e11.   Open Access
  50. BENDER, R. & LANGE, S. (2007):   Die Vierfeldertafel.   Dtsch. Med. Wschr. 132, e12-e14.   Open Access
  51. BENDER, R. & LANGE, S. (2007):   Was ist der p-Wert?   Dtsch. Med. Wschr. 132, e15-e16.   Open Access
  52. BENDER, R. & LANGE, S. (2007):   Was ist ein Konfidenzintervall?   Dtsch. Med. Wschr. 132, e17-e18.   Open Access
  53. LANGE, S. & BENDER, R. (2007):   Was ist ein Signifikanztest? Allgemeine Aspekte.   Dtsch. Med. Wschr. 132, e19-e21.   Open Access
  54. BENDER, R. & LANGE, S. (2007):   Verlaufskurven.   Dtsch. Med. Wschr. 132, e22-e23.   Open Access
  55. BENDER, R., LANGE, S. & ZIEGLER, A. (2007):   Wichtige Signifikanztests.   Dtsch. Med. Wschr. 132, e24-e25.   Open Access
  56. BENDER, R., LANGE, S. & ZIEGLER, A. (2007):   Multiples Testen.   Dtsch. Med. Wschr. 132, e26-e29.   Open Access
  57. BENDER, R., ZIEGLER, A. & LANGE, S. (2007):   Multiple Regression.   Dtsch. Med. Wschr. 132, e30-e32.   Open Access
  58. BENDER, R., ZIEGLER, A. & LANGE, S. (2007):   Logistische Regression.   Dtsch. Med. Wschr. 132, e33-e35.   Open Access
  59. ZIEGLER, A., LANGE, S. & BENDER, R. (2007):   Überlebenszeitanalyse: Eigenschaften und Kaplan-Meier Methode.   Dtsch. Med. Wschr. 132, e36-e38.   Open Access
  60. ZIEGLER, A., LANGE, S. & BENDER, R. (2007):   Überlebenszeitanalyse: Der Log-Rang-Test.   Dtsch. Med. Wschr. 132, e38-e41.   Open Access
  61. ZIEGLER, A., LANGE, S. & BENDER, R. (2007):   Überlebenszeitanalyse: Die Cox-Regression.   Dtsch. Med. Wschr. 132, e42-e44.   Open Access
  62. KLUG, S., BENDER, R., BLETTNER, M. & LANGE, S. (2007):   Wichtige epidemiologische Studientypen.   Dtsch. Med. Wschr. 132, e45-e47.   Open Access
  63. ZIEGLER, A., LANGE, S. & BENDER, R. (2007):   Systematische Übersichten und Meta-Analysen.   Dtsch. Med. Wschr. 132, e48-e52.   Open Access
  64. LANGE, S., BENDER, R. & ZIEGLER, A. (2007):   Äquivalenzstudien und Nichtunterlegen­heitsstudien.   Dtsch. Med. Wschr. 132, e53-e56.   Open Access
  65. BENDER, R., ZIEGLER, A. & LANGE, S. (2007):   Varianzanalyse.   Dtsch. Med. Wschr. 132, e57-e60.   Open Access
  66. BENDER, R., GROUVEN & ZIEGLER, A. (2007):   Varianzanalyse für Messwertwiederholungen.   Dtsch. Med. Wschr. 132, e61-e64.   Open Access
  67. GROUVEN, U., BENDER, R., ZIEGLER, A. & LANGE, S. (2007):   Der Kappa-Koeffizient.   Dtsch. Med. Wschr. 132, e65-e68.   Open Access
  68. GROUVEN, BENDER, R., ZIEGLER, A. & LANGE, S. (2007):   Vergleich von Messmethoden.   Dtsch. Med. Wschr. 132, e69-e73.   Open Access

  69. KÜCHENHOFF, H., BENDER, R. & LANGNER, I. (2007):
    Effect of Berkson measurement error on parameter estimates in Cox regression models.
    Lifetime Data Anal. 13, 261-272.

  70. KUTSCHMANN, M., BENDER, R., GROUVEN, U. & BERG, G. (2006):
    Aspekte der Fallzahlkalkulation und Powerberechnung anhand von Beispielen aus der rehabilitationswissenschaftlichen Forschung.
    Rehabilitation 45, 377-384.

  71. BENDER, R., ZEEB, H., SCHWARZ, M., JÖCKEL, K.-H. & BERGER, M. (2006):
    Causes of death in obesity: Relevant increase in cardiovascular but not in all-cancer mortality.
    J. Clin. Epidemiol. 59, 1064-1071.

  72. HILDEBRANDT, M., BENDER, R., GEHRMANN, U. & BLETTNER, M. (2006):
    Calculating confidence intervals for impact numbers.
    BMC Med. Res. Methodol. 6, 32.   Open Access   Highly accessed

  73. BENDER, R., HILDEBRANDT, M. & KUSS, O. (2006):
    Die Berechnung adjustierter NNEs in Kohortenstudien.
    In: KAISER, K. & BÖDEKER, R.-H. (Eds.): Statistik und Datenanalyse mit SAS® − Proceedings der 10. Konferenz für SAS-Anwender in Forschung und Entwicklung (KSFE), pp. 19-33.  Shaker, Aachen.   Open Access

  74. BENDER, R. & GROUVEN, U. (2006):
    Möglichkeiten und Grenzen statistischer Regressionsmodelle zur Berechnung von Schwellenwerten für Mindestmengen.
    Z. ärztl. Fortbild. Qual. Gesundh.wes. 100, 93-98.

  75. SAWICKI, P.T., BENDER, R., SELKE, G.W., KLAUBER, J. & GUTSCHMIDT, S. (2006):
    Schätzung der unter Rofecoxib (Vioxx®) in Deutschland in den Jahren 2001-2004 aufgetretenen kardio- und zerebrovaskulären Ereignisse.
    Med. Klin. 101, 191-197.

  76. BENDER, R., AUGUSTIN, T. & BLETTNER, H.(2005):
    Generating survival times to simulate Cox proportional hazards models.
    Stat. Med. 24, 1713-1723.    Corresponding Letter:   Stat. Med. 25 (2006), 1978-1979.

  77. BENDER, R., BERG, G. & ZEEB, H. (2005):
    Tutorial: Using confidence curves in medical research.
    Biom. J. 47, 237-247.

  78. MEYER, G., KÖPKE, S., BENDER, R., & MÜHLHAUSER, I. (2005):
    Predicting the risk of falling - efficacy of a risk assessment tool compared to nurses' judgement: A cluster-randomised controlled trial [ISRCTN37794278].
    BMC Geriatr. 5, 14.   Open Access

  79. SÄMANN, A., MÜHLHAUSER, I., BENDER, R., KLOOS, C & MÜLLER, U.A. (2005):
    Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: Prospective implementation study.
    Diabetologia 48, 1965-1970.   Open Access

  80. BENDER, R. (2005):   Number needed to treat (NNT).
    In:   ARMITAGE, P. & COLTON, T. (Eds.): Encyclopedia of Biostatistics, Vol. 6 (2nd Ed.), pp. 3752-3761.   Wiley, Chichester.

  81. WARNKE, A., MEYER, G., BENDER, R. & MÜHLHAUSER, I. (2004):
    Predictors of adherence to the use of hip protectors in nursing home residents.
    J. Am. Geriatr. Soc. 52, 340-345.

  82. LOBNIG, B.M., MASLOWSKA-WESSEL, E. & BENDER, R. (2003):
    Repeatability of heart rate variability measured via spectral analysis in healthy subjects.
    J. Clin. Basic Cardiol. 6, 29-33.   Open Access

  83. BENDER, R. & KUSS, O. (2003):
    Confidence intervals for adjusted NNEs: A simulation study (Letter).
    J. Clin. Epidemiol. 56, 205-206.

  84. SEYDEL, J., ULLRICH, A., BENDER, R., FISCHBACH, W. & BLETTNER, M. (2003):
    Helicobacter pylori and carcinogenesis of gastric B-cell lymphomas.
    Int. J. Cancer 104, 646-649.   Open Access

  85. MEYER, G., WARNKE, A., BENDER, R. & MÜHLHAUSER, I. (2003):
    Effect on hip fractures of increased use of hip protectors in nursing homes: Cluster randomised controlled trial.
    BMJ 326, 76-78.   Open Access

  86. BENDER, R., JÖCKEL, K.-H., RICHTER, B., SPRAUL, M. & BERGER, M. (2002):
    Body weight, blood pressure, and mortality in a cohort of obese patients.
    Am. J. Epidemiol. 156, 239-245.   Open Access

  87. BENDER, R. & BLETTNER, M. (2002):
    Calculating the "number needed to be exposed" with adjustment for confounding variables in epidemiological studies.
    J. Clin. Epidemiol. 55, 525-530.

  88. BENDER, R. (2002):
    Reply to "Simple and effective confidence intervals for the number needed to treat".
    Control. Clin. Trials 23, 101-102.

  89. SADDIG, C., BENDER, R. & STARKE, A.A.R. (2002):
    A new classification plot for the C-peptide suppression test.
    J. Pancreas 3, 16-25.   Open Access

  90. MEINHOLD, J., MASLOWSKA-WESSEL, E., BENDER, R. & SAWOCKI, P.T. (2001):
    Low prevalence of cardiac autonomic neuropathy in Type 1 diabetic patients without nephropathy.
    Diabet. Med. 18, 607-613.

  91. BENDER, R. & LANGE, S. (2001):
    Adjusting for multiple testing - when and how ?
    J. Clin. Epidemiol. 54, 343-349.

  92. BENDER, R. (2001):
    Calculating confidence intervals for the number needed to treat.
    Control. Clin. Trials 22, 102-110.

  93. BENDER, R. (2001):
    Interpretation von Effizienzmaßen der Vierfeldertafel für Diagnostik und Behandlung.
    Med. Klin. 96, 116-121.     Correction:  Med. Klin. 96, 181.

  94. BENDER, R. (2000):
    Calculating summary measures of unimodal response curves by means of nonlinear regression models.
    J. Theor. Med. 2, 73-89.

  95. MÜHLHAUSER, I., OVERMANN, H., BENDER, R., JÖRGENS, V. & BERGER, M. (2000):
    Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy.
    Diabet. Med. 17, 727-734.

  96. MÜHLHAUSER, I., SAWICKI, P.T., BLANK, M., OVERMANN, H., BENDER, R. & BERGER, M. (2000):
    Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy.
    J. Intern. Med. 248, 333-341.   Open Access

  97. BENDER, R. & BENNER, A. (2000):
    Calculating ordinal regression models in SAS and S-Plus.
    Biom. J. 42, 677-699.

  98. BENDER, R. (2000):
    Improving the calculation of confidence intervals for the number needed to treat.
    In: HASMAN, A., BLOBEL, B., DUDECK, J., ENGELBRECHT, R., GELL, G. & PROKOSCH, H.-U. (Eds.): Medical Infobahn for Europe (Proc. of the MIE2000 and GMDS2000), pp. 29-32.
    IOS Press, Amsterdam.

  99. BENDER, R. (2000):
    Berechnung von Konfidenzintervallen für die Zahl "Number Needed to Treat" (NNT).
    In: BÖDEKER, R.-H. & HOLLENHORST, M. (Eds.): Proc. der 4. Konferenz für SAS-Anwender in Forschung und Entwicklung, pp. 1-7.
    AG Statistik des Inst. für Med. Informatik, Gießen.   Open Access

  100. RICHTER, B., BENDER, R. & BERGER, M.(2000):
    Effects of on-demand ß2-agonist inhalation in moderate-to-severe asthma. A randomized controlled trial.
    J. Intern. Med. 247, 657-666.   Open Access

  101. SAWICKI, P.T., BENDER, R., BERGER, M. & MÜHLHAUSER, I. (2000):
    Non-linear effects of blood pressure and glycosylated haemoglobin on progression of diabetic nephropathy.
    J. Intern. Med. 247, 131-138.   Open Access

  102. RICHTER, B. & BENDER, R. (2000):
    Kritische Bewertung von Theraphieverfahren.
    In: BERGER, M. (Hrsg.): Diabetes mellitus (2. Aufl.), pp. 223-233. Urban & Fischer, München.

  103. BENDER, R. & KIMMERLE, R. (1999):
    Assessment of glycemic thresholds for fetal macrosomia in pregnant diabetic women.
    In: VICTOR, N., BLETTNER, M., EDLER, L., HAUX, R., KNAUP-GREGORI, P., PRITSCH, M., WAHRENDORF, J., WINDELER, J. & ZIEGLER, S. (Eds.): Medical Informatics, Biostatistics and Epidemiology for Efficient Health Care and Medical Research (Contributions from the 44th Annual Conference of the GMDS), pp. 115-116.   Urban & Vogel, München.

  104. TROCHA, A., SCHMIDTKE, C., DIDJURGEIT, U., MÜHLHAUSER, I., BENDER, R., BERGER, M. & SAWICKI, P.T. (1999):
    Effects of intensified antihypertensive treatment in diabetic nephropathy: Mortality and morbidity results of a prospective controlled 10-year study.
    J. Hypertens. 17, 1497-1503.

  105. BENDER, R. (1999):
    Quantitative risk assessment in epidemiological studies investigating threshold effects.
    Biom. J. 41, 305-319.

  106. BENDER, R., JÖCKEL, K.-H., TRAUTNER, C., SPRAUL, M. & BERGER, M. (1999):
    Effect of age on excess mortality in obesity.
    JAMA 281, 1498-1504.   Open Access

  107. RAVE, K., BENDER, R., HEISE, T. & SAWICKI, P.T. (1999):
    Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy.
    J. Hypertens. 17, 597-601.

  108. BENDER, R. & LANGE, S. (1999):
    Multiple test procedures other than Bonferroni's deserve wider use (Letter).
    BMJ 318, 600-601.   Open Access

  109. KIMMMERLE, R., HEINEMANN, L., HEISE, T., BENDER, R., WEYER, C., HIRSCHBERGER, S. & BERGER, M. (1999):
    Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
    Menopause 6, 36-42.

  110. MÜHLHAUSER, I., OVERMANN, H., BENDER, R., BOTT, U., & BERGER, M. (1998):
    Risk factors of severe hypoglycaemia in adult patients with Type 1 diabetes - a prospective population based study.
    Diabetologia 41, 1274-1282.   Open Access

  111. MÜHLHAUSER, I., OVERMANN, H., BENDER, R., BOTT, U., JÖRGENS, V., TRAUTNER, C., SIEGRIST, J. & BERGER, M. (1998):
    Social status and the quality of care for adult people with Type I (insulin-dependent) diabetes mellitus - a population based study.
    Diabetologia 41, 1139-1150.   Open Access

  112. BENDER, R. & GROUVEN, U. (1998):
    Using binary logistic regression models for ordinal data with non-proportional odds.
    J. Clin. Epidemiol. 51, 809-816.

  113. BENDER, R., LANGE, S., FREITAG, M. & TRAMPISCH, H.J. (1998):
    Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence (Letter).
    Stat. Med. 17, 946-947.

  114. BENDER, R., TRAUTNER, C., SPRAUL, M. & BERGER, M. (1998):
    Assessment of excess mortality in obesity.
    Am. J. Epidemiol. 147, 42-48.   Open Access

  115. SAWICKI, P.T., KIWITT, S., BENDER, R. & BERGER, M. (1998):
    The value of the QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus.
    J. Intern. Med. 243, 49-56.   Open Access

  116. BENDER, R. & GROUVEN, U. (1997):
    Ordinal logistic regression in medical research.
    J. R. Coll. Physic. London 31, 546-551.

  117. BENDER, R., TRAUTNER, C, SPRAUL, M. & BERGER, M. (1997):
    Die Übersterblichkeit bei Übergewicht − Die Düsseldorf Obesity Mortality Study (DOMS).
    In: MUCHE, R., BÜCHELE, G., HARDER, D. & GAUS, W. (Eds.): Medizinische Informatik, Biometrie und Epidemiologie − GMDS '97 (Proc. 42. Jahrestagung der GMDS e.V.), pp. 459-463.   MMV Medizin Verlag, München.

  118. BENDER, R. (1997):
    Square dance and probability (Letter).
    EAASDC Bull. 18 (No. 5), 19-20.

  119. BENDER, R. & GROUVEN, U. (1996):
    Logistic regression models used in medical research are poorly presented (Letter).
    BMJ 313, 628.

  120. BENDER, R. (1996):
    Calculating confidence intervals for summary measures of individual curves via nonlinear regression.
    Int. J. Biomed. Comput. 41, 13-18.

  121. BENDER, R. (1996):
    The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved (Letter).
    Diabetologia 39, 368-369.

  122. MÜHLHAUSER, I., BENDER, R., BOTT, U., JÖRGENS, V., GRÜSSER, M., WAGENER, W., OVERMANN, H. & BERGER, M. (1996):
    Cigarette smoking and progression of retinopathy and nephropathy in Type 1 diabetes.
    Diabet. Med. 13, 536-543.

  123. MÜHLHAUSER, I., PRANGE, K., SAWICKI, P.T., BENDER, R., DWORSCHAK, A., SCHADEN, W. & BERGER, M. (1996):
    Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.
    Diabetologia 39, 212-219.

  124. SAWICKI, P.T., DÄHNE, R., BENDER, R. & BERGER, M. (1996):
    Prolonged QT interval as a predictor of mortality in diabetic nephropathy.
    Diabetologia 39, 77-81.

  125. BENDER, R. & SAWICKI, P.T. (1996):
    Effect of intensive treatment in insulin dependent diabetes mellitus with microalbuminuria (Letter).
    BMJ 312, 254.

  126. HEINEMANN, L., HEISE, T., KLEPPER, A., AMPUDIA, J., BENDER, R. & STARKE, A.A.R. (1995):
    Time action profiles of the intermediate-acting insulin analogue: Des(64,65)-human proinsulin.
    Diabetes Metab. 21, 415-419.

  127. BENDER, R. & HEINEMANN, L. (1995):
    Fitting nonlinear regression models with correlated errors to individual pharmacodynamic data using SAS software.
    J. Pharmacokin. Biopharm. 23, 87-100.

  128. SAWICKI, P.T., MÜHLHAUSER, I., DIDJURGEIT, U., BAUMGARTNER, A., BENDER, R. & BERGER, M. (1995):
    Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy.
    J. Hypertens. 13, 933-938.

  129. MÜHLHAUSER, I., BOTT, U., OVERMANN, H., WAGENER, W., BENDER, R., JÖRGENS, V. & BERGER, M. (1995):
    Liberalized diet in patients with type 1 diabetes.
    J. Intern. Med. 237, 591-597.

  130. KIMMERLE, R, Z, R.-P., SOMVILLE, T., BENDER, R., PAWLOWSKI, B. & BERGER, M. (1995):
    Pregnancies in women with diabetic nephropathy: Long-term outcome for mother and child.
    Diabetologia 38, 227-235.

  131. BENDER, R. & HEINEMANN, L. (1994):
    Description of peaked curves by means of exponential functions.
    In: PÖPPL, S.J., LIPINSKI, H.-G. & MANSKY, T. (Eds.): Medizinische Informatik: Ein integrierender Teil arztunterstützender Technologien (Proc. 38. Jahrestagung der GMDS e.V.), pp. 482-485.   MMV, München.

  132. BENDER, R. (1994):
    Determination of the area under a curve (Letter).
    Diabetes Care 17, 1223.   Open Access

  133. SAWICKI, P.T., DIDJURGEIT, U., MÜHLHAUSER, I., BENDER, R., HEINEMANN, L. & BERGER, M. (1994):
    Smoking is associated with progression of diabetic nephropathy.
    Diabetes Care 17, 126-131.   Open Access

  134. BENDER, R. (1993):
    Using common statistical program packages for the Friedman test when ties are among treatments and a multiple comparison procedure is needed.
    Comput. Statist. Data Anal. 16, 365-369.

  135. BENDER, R. & GROUVEN, U. (1993):
    On the choice of the number of residual autocovariances for the portmanteau test of multivariate autoregressive models.
    Commun. Statist. - B 22, 19-32.

  136. BENDER, R., SCHULTZ, B. & GROUVEN, U. (1993):
    Classification of EEG signals into general stages of anesthesia in real-time using autoregressive models.
    In: OPITZ, O., LAUSEN, B. & KLAR, R. (Eds.): Information and Classification: Concepts, Methods and Application (Proc. of the 16th Annual Conference of the "Gesellschaft für Klassifikation"), pp. 443-452.   Springer, Berlin.

  137. SCHULTZ, B., BENDER, R., SCHULTZ, A. & PICHLMAYR, I. (1992):
    Reduktion der Anzahl von EEG-Ableitung für ein routinemäßiges Monitoring auf der Intensivstation.
    Biomed. Techn. 37, 194-199.   Open Access

  138. GROUVEN, U., BENDER, R., SCHULTZ, A. & PICHLMAYR, R. (1992):
    Application of adjusted survival curves to renal transplant data.
    Meth. Inf. Med. 31, 210-214.   Open Access

  139. BENDER, R., SCHULTZ, B., SCHULTZ, A. & PICHLMAYR, I. (1992):
    Testing the Gaussianity of the human EEG during anesthesia.
    Meth. Inf. Med. 31, 56-59.   Open Access

  140. BENDER, R., SCHULTZ, B., SCHULTZ, A. & PICHLMAYR, I. (1991):
    Identification of EEG patterns occuring in anesthesia by means of autoregressive parameters.
    Biomed. Techn. 36, 236-240.   Open Access

  141. BENDER, R. & WOLTERING, F. (1991):
    Heritabilitätsschätzungen bei ordinalen Daten.
    Forschungsbericht Nr. 91/1, FB Statistik der Universität Dortmund.


Do you need a reprint?

Send me a request:   E-Mail Ralf.Bender@iqwig.de


Line


Back Back to my statistics page      Home Back to my start page


© 25.01.2017 Ralf Bender